Celixir

📍 Cardiff, United Kingdom🗓 Founded 2009👥 7 employees💰 Last funded Jun 2018
Biotechnology Research🌐 celixir.com
Website LinkedIn
Celixir (formerly known as Cell Therapy Ltd.) is a private British regenerative medicine company that discovers and develops life-saving and life-altering regenerative medicines for patients with the greatest medical need. Celixir, founded in 2009, is made up of a world-class team of scientists and biopharmaceutical executives, led by Nobel Laureate Professor Sir Martin Evans and former Roche Global Head of Emerging Technologies, Ajan Reginald. Celixir’s unique platform technology allows us to adopt an ‘off-the-shelf’ approach to deliver regenerative medicines to patients.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Celixir?
Celixir has 1 investors on record on gritt.io and 1 late-stage investors.
When did Celixir last raise funding?
The most recent investment in Celixir recorded on gritt.io was in June 2018.
When was Celixir founded?
Celixir was founded in 2009.
What industry is Celixir in?
Celixir operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Celixir based?
Celixir is headquartered in Cardiff, United Kingdom.